Clinical Study
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study
Table 3
Best response of the metronomic combination of VRB and CAPE according to RECIST criteria. .
|